|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Gottlieb, S. 2004. Vaccine Makers Get a Shot in the Arm. Available: http://www.forbes.com/2004/10/11/cz_sg_1011soapbox.html [accessed November 23, 2009]. Gross, C.P., G.F. Anderson, and N.R. Powe. 1999. The relation between funding by the National Institutes of Health and the burden of disease. NELM 340(24):1881-1887. HHS (Department of Health and Human Services). 2008 (November). Draft Strategic National Vaccine Plan. Available: http://www.hhs.gov/nvpo/vacc_plan/2008plan/draftvaccineplan.pdf [accessed December 2008]. HHS. 2009. BARDA Influenza & Emerging Disease Program. Available: http://www.hhs.gov/aspr/barda/mcm/panflu/index.html [accessed November 23, 2009]. HHS, NIH (National Institutes of Health), and NIAID (National Institute of Allergy and Infectious Diseases). 2002. The Jordan Report, 20th Anniversary: Accelerated Development of Vaccines. Washington, DC: HHS. HHS, NIH, and NIAID. 2007. The Jordan Report, Accelerated Development of Vaccines. Washington, DC: HHS. Hoyt, K. 2006. Vaccine innovation: Lessons from World War II. J Public Health Pol 27(1): 38-60. Hynes, N.A. 2007. Project bioshield a tool for developing, using, and stockpiling needed public health emergency medical countermeasures. The Jordan Report, Accelerated Development of Vaccine 2007 27-36. IOM (Institute of Medicine). 1985a. New Vaccine Development: Establishing Priorities: Volume 2, Diseases of Importance in Developing Countries. Washington, DC: National Academy Press. IOM. 1985b. New Vaccine Development: Establishing Priorities: Volume 1, Diseases of Importance in the United States. Washington, DC: National Academy Press. IOM. 2000. Vaccines for the 21st Century. Washington, DC: National Academy Press. IOM. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press. IOM. 2008 (December 1). Transcript, Second National Stakeholder Meeting of the IOM Committee on Review of Priorities in the National Vaccine Plan. Irvine, CA: IOM. Kataoka, M., A. Yamamoto, M. Ochiai, A. Harashima, N. Nagata, H. Hasegaw, T. Kurata, and Y. Horiuchi. 2009. Comparison of acellular pertussis-based combination vaccines by Japanese control tests for toxicities and laboratory models for local reaction. Vaccine 27:1881-1888. Klein, J.O., and M.G. Myers. 2006. Strengthening the supply of routinely administered vaccines in the United States: Problems and proposed solutions. Clin Infect Dis 42(Suppl 3):S97-S103. Landry, S., and C. Heilman. 2005. Future directions in vaccines: The payoffs of basic research. Health Aff 24(3):758-769. Miller, H.I., and D.R. Henderson. 2007. Governmental influences on drug development: Striking a better balance. Nat Rev Drug Discov 6(7):532-539. Milstien, J.B. 2004. Regulation of vaccines: Strengthening the science base. J Public Health Pol 25(2):173-189. Nature Reviews Drug Discovery. 2008. The drought continues. Nature 7:105. Neumann, P.J., A.B. Rosen, D. Greenberg, N.V. Olchanski, R. Pande, R.H. Chapman, P.W. Stone, S. Ondategui-Parra, J. Nadai, J.E. Siegel, and M.C. Weinstein. 2005. Can we better prioritize resources for cost-utility research? Med Decis Making 25(4):429-436. NIH (National Institutes of Health). 2009a. Research Project Grants: New (type 1) Awards and Percentage to Targeted Research. Available: http://report.nih.gov/nihdatabook/Charts/SlideGen.aspx?chartId=25&catId=2 [accessed October 2009]. NIH. 2009b. R01-Equivalent Grants: Awards as a Percentage of all Research Grants. Available: http://report.nih.gov/nihdatabook/Charts/SlideGen.aspx?chartId=32&catId=2 [accessed October 2009].
|
|
|||||||||||||||
